arrow
N

Nitsan Maharshak

tel-aviv sourasky university medical center
H指数:43
被引数:8,590

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative effectiveness and safety of first-line anti-TNF, vedolizumab, and ustekinumab in biologic-naïve Crohn’s disease: Analysis from a real-world cohort

生物制剂初治克罗恩病患者中一线抗-TNF、 vedolizumab 和 ustekinumab 的比较有效性与安全性:真实世界队列分析

2026-10-030
OA
Global Roll-Out and Continued Multi-Site Validation of the Artificial Intelligence Histology Instrument for Qualitative Assessment of Histopathology in Ulcerative Colitis

全球推广及人工智能组织学仪器在溃疡性结肠炎组织病理学定性评估中的多中心持续验证

2026-07-300
OAAI
Isoperistaltic Anastomosis Increases Neo-Terminal Ileum Intubation Rates in Crohn's Disease Patients (Vol 313, pg 421, 2025)

等蠕动吻合术可提高克罗恩病患者新末端回肠插管率(卷313,页421,2025年)

2025-10-010
OAAI
Deep phenotyping of health–disease continuum in the Human Phenotype Project

人类表型项目中健康-疾病连续体的深度表型分析

2025-07-150
PRE
Bronchiectasis in Patients With Inflammatory Bowel Diseases

炎症性肠病患者中的支气管扩张

CHEST
IF8.6
2025-03-280
PRE
Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real-Life Retrospective Multicentre Cohort Study
2024-10-284
OAAI
Faecal Transplantation for Ulcerative Colitis From Diet Conditioned Donors Followed by Dietary Intervention Results in Favourable Gut Microbial Profile Compared to Faecal Transplantation Alone
2024-05-091
PRE
Curcumin-QingDai Combination for Patients With Active Ulcerative Colitis: A Randomized, Double-Blinded, Placebo-Controlled Trial

姜黄素-青黛联合治疗活动性溃疡性结肠炎: 一项随机、双盲、安慰剂对照试验

2024-02-0118
PRE